PMV Pharmaceuticals is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies that target p53 mutations.
$33.00 +0.28 (0.86%)
As of 04/14/2021 15:59:44 EST IEX book CBOE book
2021 © Stock Market MBA, Inc.